JP2016500073A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500073A5
JP2016500073A5 JP2015543098A JP2015543098A JP2016500073A5 JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5 JP 2015543098 A JP2015543098 A JP 2015543098A JP 2015543098 A JP2015543098 A JP 2015543098A JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5
Authority
JP
Japan
Prior art keywords
carboxamide
pyrazine
methyl
imidazo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/070623 external-priority patent/WO2014078813A1/en
Publication of JP2016500073A publication Critical patent/JP2016500073A/ja
Publication of JP2016500073A5 publication Critical patent/JP2016500073A5/ja
Pending legal-status Critical Current

Links

JP2015543098A 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物 Pending JP2016500073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728024P 2012-11-19 2012-11-19
US61/728,024 2012-11-19
PCT/US2013/070623 WO2014078813A1 (en) 2012-11-19 2013-11-18 Compounds and compositions for the treatment of parasitic diseases

Publications (2)

Publication Number Publication Date
JP2016500073A JP2016500073A (ja) 2016-01-07
JP2016500073A5 true JP2016500073A5 (enExample) 2016-12-28

Family

ID=49667633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543098A Pending JP2016500073A (ja) 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物

Country Status (5)

Country Link
US (1) US20150291598A1 (enExample)
EP (1) EP2920177A1 (enExample)
JP (1) JP2016500073A (enExample)
CN (1) CN105189506A (enExample)
WO (1) WO2014078813A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME03042B (me) 2012-11-19 2018-10-20 Novartis Ag Jedinjenja i kompozicije za tretman parazitskih oboljenja
EP2920177A1 (en) * 2012-11-19 2015-09-23 Novartis AG Compounds and compositions for the treatment of parasitic diseases
KR102565544B1 (ko) * 2014-06-25 2023-08-10 에프. 호프만-라 로슈 아게 척수성 근위축증을 치료하기 위한 이미다조[1,2-a]피라진-1일-벤즈아마이드 화합물
PE20171307A1 (es) 2014-12-23 2017-09-05 Novartis Ag Compuestos de triazolopirimidina y usos de los mismos
CN104610229B (zh) * 2015-01-21 2017-01-18 上海皓元生物医药科技有限公司 一种是atp竞争性小分子akt抑制剂a443654的合成方法
MX388824B (es) 2016-06-20 2025-03-20 Novartis Ag Formas cristalinas de compuesto de triazolopirimidina.
ES2798424T3 (es) 2016-06-20 2020-12-11 Novartis Ag Compuestos de triazolopiridina y usos de estos
EP3472166A1 (en) 2016-06-20 2019-04-24 Novartis AG Imidazopyrimidine compounds useful for the treatment of cancer
GB201700692D0 (en) * 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis
CN110582498B (zh) * 2017-04-27 2022-06-24 日本农药株式会社 缩合杂环化合物或其盐类、以及含有这些化合物的农业园艺用杀虫剂及其使用方法
US11584744B2 (en) * 2017-06-23 2023-02-21 University Of Washington Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them
WO2019002606A1 (en) * 2017-06-30 2019-01-03 Selvita S.A. ADENOSINE A2A RECEPTOR 5,6-BICYCLO-IMIDAZO [1,2-A] PYRAZINE MODULATORS
CN110168093B (zh) * 2017-09-12 2023-08-15 中科蓝华(广州)生物医药技术有限公司 一种转染细胞内寄生虫的试剂盒及其应用
CN111867581B (zh) 2018-01-29 2023-12-26 默克专利股份有限公司 Gcn2抑制剂及其用途
US10239885B1 (en) 2018-06-18 2019-03-26 Avista Pharma Solutions, Inc. Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-α]pyrazin-3-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist
GB201811695D0 (en) * 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
TWI811428B (zh) 2018-08-21 2023-08-11 日商杏林製藥股份有限公司 雙環雜芳香環衍生物
MX2021006696A (es) 2018-12-06 2021-07-07 Daiichi Sankyo Co Ltd Derivado de cicloalcano-1,3-diamina.
MX2021009251A (es) 2019-01-30 2021-09-21 Avista Pharma Solutions Inc Proceso de sintesis y nuevos compuestos intermedios.
WO2020160075A1 (en) 2019-01-30 2020-08-06 Avista Pharma Solutions, Inc. Chemical compounds
PE20221318A1 (es) 2019-10-21 2022-09-08 Novartis Ag Compuestos y composiciones para el tratamiento de enfermedades parasitarias
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
CN121002016A (zh) * 2023-04-13 2025-11-21 先正达农作物保护股份公司 咪唑并[1,2-a]吡啶衍生物
TW202446263A (zh) * 2023-04-13 2024-12-01 瑞士商先正達農作物保護股份公司 殺真菌組成物
AR132358A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados bicíclicos de imidazo
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina
CN120957990A (zh) * 2023-04-13 2025-11-14 先正达农作物保护股份公司 咪唑并[1,2-a]吡啶衍生物
WO2024213651A1 (en) * 2023-04-13 2024-10-17 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EA200900983A1 (ru) * 2007-01-26 2010-02-26 Айрм Ллк Соединения и композиции в качестве ингибиторов киназы
UY32776A (es) * 2009-07-09 2011-02-28 Irm Llc Compuestos de imidazopirazinas sustituidas para el tratamiento de enfermedades parasitarias,composiciones farmacéuticas que los contienen y aplicación.
EP2920177A1 (en) * 2012-11-19 2015-09-23 Novartis AG Compounds and compositions for the treatment of parasitic diseases

Similar Documents

Publication Publication Date Title
JP2016500073A5 (enExample)
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
ES2968796T3 (es) Derivados de tiadiazolilo como inhibidores de la ADN polimerasa theta
ES2778700T3 (es) Nuevos derivados de piperidinilo sustituidos con (hetero)arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2015522002A5 (enExample)
KR101819433B1 (ko) 인돌린-2-온 또는 피롤로-피리딘-2-온 유도체
JP2017530960A5 (enExample)
RU2017105296A (ru) Новые соединения
JP2013508404A5 (enExample)
JP2020527560A5 (enExample)
JP2020514267A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017510576A5 (enExample)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2017520607A (ja) 置換尿素誘導体及びその薬学的使用
JP2016500073A (ja) 寄生虫病の処置のための化合物および組成物
JP2016519096A5 (enExample)
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
JP2016507551A5 (enExample)
JP2014511355A5 (enExample)
IL310330A (en) Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
WO2017102091A1 (en) Heteroarylbenzimidazole compounds
JPWO2020052631A5 (enExample)
WO2024015497A1 (en) Tyrosine kinase 2 inhibitors and uses thereof